User profiles for A. Murumagi

Astrid Murumagi

Senior Scientist, FIMM, Helsinki University
Verified email at helsinki.fi
Cited by 976

Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia

…, MM Majumder, JML Marti, P Mattila, A Murumägi… - Cancer discovery, 2013 - AACR
We present an individualized systems medicine (ISM) approach to optimize cancer drug
therapies one patient at a time. ISM is based on (i) molecular profiling and ex vivo drug …

[HTML][HTML] Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1

…, K Visvalingam, P Peterson, K Möll, A Murumägi… - PLoS …, 2006 - journals.plos.org
Background The autoimmune regulator (AIRE) gene influences thymic self-tolerance induction.
In autoimmune polyendocrinopathy syndrome type 1 (APS1; OMIM 240300), recessive …

[HTML][HTML] Identification of fusion genes in breast cancer by paired-end RNA-sequencing

H Edgren, A Murumagi, S Kangaspeska, D Nicorici… - Genome biology, 2011 - Springer
Background Until recently, chromosomal translocations and fusion genes have been an
underappreciated class of mutations in solid tumors. Next-generation sequencing technologies …

Colorectal cancer consensus molecular subtypes translated to preclinical models uncover potentially targetable cancer cell dependencies

…, PW Eide, IA Eilertsen, L Ramirez, A Murumägi… - Clinical Cancer …, 2018 - AACR
Purpose: Response to standard oncologic treatment is limited in colorectal cancer. The
gene expression–based consensus molecular subtypes (CMS) provide a new paradigm for …

FusionCatcher–a tool for finding somatic fusion genes in paired-end RNA-sequencing data

…, M Şatalan, H Edgren, S Kangaspeska, A Murumägi… - biorxiv, 2014 - biorxiv.org
FusionCatcher is a software tool for finding somatic fusion genes in paired-end RNA-sequencing
data from human or other vertebrates. FusionCatcher achieves competitive detection …

Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes

…, A Meager, L Tserel, T Org, A Murumägi… - Blood, The Journal …, 2008 - ashpublications.org
Neutralizing autoantibodies to type I, but not type II, interferons (IFNs) are found at high titers
in almost every patient with autoimmune polyendocrinopathy candidiasis ectodermal …

Targeting ROR1 identifies new treatment strategies in hematological cancers

H Karvonen, W Niininen, A Murumägi… - Biochemical Society …, 2017 - portlandpress.com
Receptor tyrosine kinase-like orphan receptor 1 (ROR1) is a member of the ROR receptor
family consisting of two closely related type I transmembrane proteins ROR1 and ROR2. …

Haematological health state indices of reproducing great tits: methodology and sources of natural variation

I Ots, A Murumägi, P Horak - Functional Ecology, 1998 - Wiley Online Library
1. A cornerstone concept of ecological immunology is that immune function, interacting with
various aspects of individual health state, plays a central role in the life‐history trade‐offs …

[HTML][HTML] Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies

…, MM Majumder, D Malani, A Murumägi… - Scientific reports, 2014 - nature.com
We developed a systematic algorithmic solution for quantitative drug sensitivity scoring (DSS),
based on continuous modeling and integration of multiple dose-response relationships in …

[HTML][HTML] Reanalysis of RNA-sequencing data reveals several additional fusion genes with multiple isoforms

…, S Hultsch, H Edgren, D Nicorici, A Murumägi… - PloS one, 2012 - journals.plos.org
RNA-sequencing and tailored bioinformatic methodologies have paved the way for identification
of expressed fusion genes from the chaotic genomes of solid tumors. We have recently …